What is Calidi Biotherapeutics, Inc.'s Market Cap?

Calidi Biotherapeutics, Inc.'s Market Cap is $3.5M, based on as-reported figures from SEC (XBRL) filings.

What is Calidi Biotherapeutics, Inc.'s Enterprise Value?

Calidi Biotherapeutics, Inc.'s Enterprise Value is $152.5K, based on as-reported figures from SEC (XBRL) filings.

What is Calidi Biotherapeutics, Inc.'s EV / EBITDA?

Calidi Biotherapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Calidi Biotherapeutics, Inc.'s Net Income (TTM)?

Calidi Biotherapeutics, Inc.'s Net Income (TTM) is -$17.5M, based on as-reported figures from SEC (XBRL) filings.

What is Calidi Biotherapeutics, Inc.'s EBITDA?

Calidi Biotherapeutics, Inc.'s EBITDA is -$16.1M, based on as-reported figures from SEC (XBRL) filings.

What is Calidi Biotherapeutics, Inc.'s Diluted EPS (TTM)?

Calidi Biotherapeutics, Inc.'s Diluted EPS (TTM) is -6.76, based on as-reported figures from SEC (XBRL) filings.

What is Calidi Biotherapeutics, Inc.'s Net Debt?

Calidi Biotherapeutics, Inc.'s Net Debt is -$3.4M, based on as-reported figures from SEC (XBRL) filings.

Calidi Biotherapeutics, Inc. (CLDI) Financial Statements

Calidi Biotherapeutics, Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG012QFCL93

XASE · usd

1.36▲ 0.01 (0.74%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.35

Day's Range1.30 – 1.37

52-Week Range0.09 – 1.93

Volume43.7K

Avg Volume279.1K

Share Statistics

Shares Outstanding

Employees29

ExchangeXASE

Listed2023-09-13

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Calidi Biotherapeutics, Inc. (CLDI)

What is Calidi Biotherapeutics, Inc.'s Market Cap?: Calidi Biotherapeutics, Inc.'s Market Cap is $3.5M, based on as-reported figures from SEC (XBRL) filings.
What is Calidi Biotherapeutics, Inc.'s Enterprise Value?: Calidi Biotherapeutics, Inc.'s Enterprise Value is $152.5K, based on as-reported figures from SEC (XBRL) filings.
What is Calidi Biotherapeutics, Inc.'s EV / EBITDA?: Calidi Biotherapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Calidi Biotherapeutics, Inc.'s Net Income (TTM)?: Calidi Biotherapeutics, Inc.'s Net Income (TTM) is -$17.5M, based on as-reported figures from SEC (XBRL) filings.
What is Calidi Biotherapeutics, Inc.'s EBITDA?: Calidi Biotherapeutics, Inc.'s EBITDA is -$16.1M, based on as-reported figures from SEC (XBRL) filings.
What is Calidi Biotherapeutics, Inc.'s Diluted EPS (TTM)?: Calidi Biotherapeutics, Inc.'s Diluted EPS (TTM) is -6.76, based on as-reported figures from SEC (XBRL) filings.
What is Calidi Biotherapeutics, Inc.'s Net Debt?: Calidi Biotherapeutics, Inc.'s Net Debt is -$3.4M, based on as-reported figures from SEC (XBRL) filings.